China tests U.S. cancer treatment on kids to close care gap
NCT ID NCT04726501
Summary
This study is testing a well-established cancer treatment plan, originally developed in the U.S., on Chinese children and teenagers newly diagnosed with Hodgkin lymphoma. The goal is to see if this plan works as effectively in China, where the disease is rarer and drug access can be difficult, by measuring survival rates and identifying problems in current care. About 200 participants, aged 1 to 18, will receive chemotherapy and sometimes radiation, with treatment intensity based on how advanced their cancer is.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nanjing Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
Nanjing, China
-
Shanghai Children's Medical Center
Shanghai, 200127, China
-
West China Second University Hospital, Sichuan University, Chengdu, China
Chengdu, China
Conditions
Explore the condition pages connected to this study.